{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:59:53Z","timestamp":1794409193062,"version":"4.9.0"},"publisher-location":"Totowa, NJ","reference-count":61,"publisher":"Humana Press","isbn-type":[{"value":"9781617794971","type":"print"},{"value":"9781617794988","type":"electronic"}],"license":[{"start":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T00:00:00Z","timestamp":1324857600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2011,12,26]],"date-time":"2011-12-26T00:00:00Z","timestamp":1324857600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-61779-498-8_21","type":"book-chapter","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T15:21:16Z","timestamp":1326813676000},"page":"323-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Proteoglycans and Osteolysis"],"prefix":"10.1007","author":[{"given":"Marc","family":"Baud\u2019Huin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9line","family":"Charrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gwenola","family":"Bougras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9gis","family":"Brion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Lezot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Padrines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Heymann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,26]]},"reference":[{"key":"21_CR1_21","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s11154-006-9009-x","volume":"7","author":"A Bruzzaniti","year":"2006","unstructured":"Bruzzaniti, A. and Baron, R. (2006) Molecular regulation of osteoclast activity. Rev Endocr Metab Disord. 7, 123\u2013139.","journal-title":"Rev Endocr Metab Disord."},{"key":"21_CR2_21","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","volume":"15","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre, S., Wittrant, Y., Kwan Tat, S., Fortun, Y., R\u00e9dini, F., and Heymann, D. (2004) The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling. Cytokine Growth Factor Rev. 15, 457\u2013475.","journal-title":"Cytokine Growth Factor Rev."},{"key":"21_CR3_21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1006\/cyto.1997.0277","volume":"10","author":"D Heymann","year":"1998","unstructured":"Heymann, D., Guicheux, J., Gouin, F., Passuti, N., and Daculsi, G. (1998) Cytokines, growth factors and osteoclasts. Cytokine 10, 155\u2013168.","journal-title":"Cytokine"},{"key":"21_CR4_21","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1007\/s00018-007-7104-0","volume":"64","author":"M Baud\u2019huin","year":"2007","unstructured":"Baud\u2019huin, M., Lamoureux, F., Duplomb, L., R\u00e9dini, F., and Heymann, D. (2007) RANKL, RANK, osteoprotegerin: key partners of osteoimmunology and vascular diseases. Cell Mol Life Sci 64, 2334\u20132350.","journal-title":"Cell Mol Life Sci"},{"key":"21_CR5_21","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S8756-3282(02)00672-5","volume":"30","author":"A-V Rousselle","year":"2002","unstructured":"Rousselle, A.-V. and Heymann, D. (2002) Osteoclastic acidification pathways during bone resorption. Bone 30, 533\u2013540.","journal-title":"Bone"},{"key":"21_CR6_21","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cytogfr.2008.11.005","volume":"20","author":"S Georges","year":"2009","unstructured":"Georges, S., Ruiz Velasco, C., Trichet, V., Fortun, Y., Heymann, D., and Padrines, M. (2009) Proteases and bone remodelling. Cytokine Growth Factor Rev 20, 29\u201341.","journal-title":"Cytokine Growth Factor Rev"},{"key":"21_CR7_21","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2217\/17460751.1.4.539","volume":"1","author":"PJ Marie","year":"2006","unstructured":"Marie, P. J. and Fromigu\u00e9, O. (2006). Osteogenic differentiation of human marrow-derived mesenchymal stem cells. Regen Med 1, 539\u2013548.","journal-title":"Regen Med"},{"key":"21_CR8_21","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1006\/cyto.2000.0765","volume":"12","author":"C Damiens","year":"2000","unstructured":"Damiens, C., Fortun, Y., Charrier, C., Heymann, D., and Padrines, M. (2000) Modulation by soluble factors of gelatinase activities released by osteoblastic cells. Cytokine 12, 1727\u20131731.","journal-title":"Cytokine"},{"key":"21_CR9_21","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1002\/bies.20612","volume":"29","author":"F Lamoureux","year":"2007","unstructured":"Lamoureux, F., Baud\u2019huin, M., Duplomb, L., Heymann, D., and R\u00e9dini, F. (2007) Proteoglycans: key partners in bone cell biology. Bioessays 29, 758\u2013771.","journal-title":"Bioessays"},{"key":"21_CR10_21","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W. J., Simonet, W. S., and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature 423, 337\ufeff\u2013342.","journal-title":"Nature"},{"key":"21_CR11_21","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.yexcr.2003.10.016","volume":"293","author":"Y Wittrant","year":"2004","unstructured":"Wittrant, Y., Theoleyre, S., Couillaud, S., Dunstan, C., Heymann, D., and R\u00e9dini, F. (2004) Relevance of an in vitro osteoclastogenesis system to study receptor activator of NF-kB ligand and osteoprotegerin biological activities. Exp Cell Res. 293, 292\ufeff\u2013301.","journal-title":"Exp Cell Res."},{"key":"21_CR12_21","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M. S., Luthy, R., et al (1997). Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309\ufeff\u2013319.","journal-title":"Cell"},{"key":"21_CR13_21","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1210\/en.139.3.1329","volume":"139","author":"H Yasuda","year":"2004","unstructured":"Yasuda, H., Shima, N., Nakagawa, N., Mochizuki, S. I., Yano, K., Fujise, N., et al. (2004) Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG\/OCIF inhibits osteoclastogenesis in vitro. Endocrinology 139, 1329\ufeff\u20131337.","journal-title":"Endocrinology"},{"key":"21_CR14_21","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1359\/jbmr.2002.17.7.1180","volume":"17","author":"A Corsi","year":"2002","unstructured":"Corsi, A., Xu, T., Chen, X. D., Boyde, A., Liang, J., Mankani, M., et al (2002) Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res. 17, 1180\ufeff\u20131189.","journal-title":"J Bone Miner Res."},{"key":"21_CR15_21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1634\/stemcells.2006-0395","volume":"25","author":"L Duplomb","year":"2007","unstructured":"Duplomb, L., Dagouassat, M., Jourdon, P., and Heymann, D. (2007) Concise review: embryonic stem cells: a new tool to study osteoblast and osteoclast differentiation. Stem Cells 25, 544\u2013552.","journal-title":"Stem Cells"},{"key":"21_CR16_21","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","volume":"15","author":"WC Raschke","year":"1978","unstructured":"Raschke, W. C., Baird, S., Ralph, P., and Nakoinz, I. (1978) Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15, 261\u2013267.","journal-title":"Cell"},{"key":"21_CR17_21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbamcr.2003.10.005","volume":"1644","author":"S Theoleyre","year":"2004","unstructured":"Theoleyre, S., Wittrant, Y., Couillaud, S., Vusio, P., Berreur, M., Dunstan, C., et al (2004) Cellular activity and signaling induced by osteoprotegerin in osteoclasts: involvement of receptor activator of nuclear factor kappaB ligand and MAPK. Biochim Biophys Acta 1644, 1\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"21_CR18_21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bone.2005.12.078","volume":"39","author":"C Blin-Wakkach","year":"2006","unstructured":"Blin-Wakkach, C., Breuil, V., Quincey, D., Bagnis, C., and Carle, G. F. (2006) Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice. Bone 39, 53\u201360.","journal-title":"Bone"},{"key":"21_CR19_21","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/jcp.22095","volume":"223","author":"F L\u00e9zot","year":"2010","unstructured":"L\u00e9zot, F, Thomas, B. L., Blin-Wakkach, C., Castaneda, B., Bolanos, A., Hotton, D., et al. (2010) Dlx homeobox gene family expression in osteoclasts. J Cell Physiol. 223, 779\u2013787.","journal-title":"J Cell Physiol."},{"key":"21_CR20_21","doi-asserted-by":"publisher","first-page":"31704","DOI":"10.1074\/jbc.M109.030312","volume":"284","author":"M Baud\u2019huin","year":"2009","unstructured":"Baud\u2019huin, M., Duplomb, L., T\u00e9letch\u00e9a, S., Charrier, C., Maillasson, M., Fouassier, M., and Heymann, D. (2009) Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival. J Biol Chem. 284, 31704\u201331713.","journal-title":"J Biol Chem."},{"key":"21_CR21_21","doi-asserted-by":"publisher","first-page":"3688","DOI":"10.1210\/en.2007-1719","volume":"149","author":"L Duplomb","year":"2008","unstructured":"Duplomb, L., Baud\u2019huin, M., Charrier, C., Berreur, M., Trichet, V., Blanchard, F., and Heymann, D. (2008) Interleukin-6 inhibits receptor activator of nuclear factor kappaB ligand-induced osteoclastogenesis by diverting cells into the macrophage lineage: key role of Serine727 phosphorylation of signal transducer and activator of transcription 3. Endocrinology 149, 3688\u20133697.","journal-title":"Endocrinology"},{"key":"21_CR22_21","first-page":"337","volume":"24","author":"HJ Knowles","year":"2009","unstructured":"Knowles, H. J. and Athanasou, N. A. (2009) Canonical and non-canonical pathways of osteoclast formation. Histol Histopathol 24, 337\u2013346.","journal-title":"Histol Histopathol"},{"key":"21_CR23_21","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/16852","volume":"397","author":"YY Kong","year":"1999","unstructured":"Kong, Y. Y., Yoshida, H., Sarosi, I., Tan, H. L., Timms, E., Capparelli, C., et al. (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315\u2013323.","journal-title":"Nature"},{"key":"21_CR24_21","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/path.2684","volume":"221","author":"M Baud\u2019Huin","year":"2010","unstructured":"Baud\u2019Huin, M., Renault, R., Charrier, C., Riet, A., Moreau, A, Brion R, et al. (2010) Interleukin-34 is expressed by giant cell tumours of bone and plays a key role in RANKL-induced osteoclastogenesis. J Pathol. 221, 77\u201386.","journal-title":"J Pathol."},{"key":"21_CR25_21","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1359\/jbmr.060409","volume":"21","author":"K Chu","year":"2006","unstructured":"Chu, K., Snyder, R., Econs, M. J., and Facp, M. D. (2006) Disease status in autosomal dominant osteopetrosis type 2 is determined by osteoclastic properties. J Bone Miner Res. 21, 1089\u20131097.","journal-title":"J Bone Miner Res."},{"key":"21_CR26_21","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1210\/en.2005-1340","volume":"147","author":"K Fuller","year":"2006","unstructured":"Fuller, K., Kirstein, B., and Chambers, T. J. (2006) Murine osteoclast formation and function: differential regulation by humoral agents. Endocrinology 147, 1979\u20131985.","journal-title":"Endocrinology"},{"key":"21_CR27_21","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.ejcb.2010.08.001","volume":"60","author":"M Baud\u2019huin","year":"2011","unstructured":"Baud\u2019huin, M., Ruiz-Velasco, C., Jego, G., Charrier, C., Gasiunas, N., Gallagher J et al (2011) Glycosaminoglycans inhibit the adherence and the spreading of osteoclasts and their precursors: Role in osteoclastogenesis and bone resorption. Eur J Cell Biol. 60, 49\u201357.","journal-title":"Eur J Cell Biol."},{"key":"21_CR28_21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1006\/cyto.1998.0429","volume":"11","author":"F Gouin","year":"1999","unstructured":"Gouin, F., Couillaud, S., Cottrel, M., Godard, A., Passuti, N., and Heymann, D. (1999) Presence of leukaemia inhibitory factor (LIF) and LIF-receptor chain (gp190) in osteoclast-like cells cultured from human giant cell tumour of bone. Ultrastructural distribution. Cytokine 11, 282\u2013289.","journal-title":"Cytokine"},{"key":"21_CR29_21","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S8756-3282(97)00224-X","volume":"22","author":"J Guicheux","year":"1998","unstructured":"Guicheux, J., Heymann, D., Rousselle, A.-V., Gouin, F., Pilet, P., Yamada, S., et al (1998) Growth hormone stimulatory effects on osteoclastic resorption are partly mediated by insulin-like growth factor I: an in vitro study. Bone 22, 25\u201331.","journal-title":"Bone"},{"key":"21_CR30_21","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1002\/jcp.20625","volume":"207","author":"V Kram","year":"2006","unstructured":"Kram, V., Zcharia, E., Yacoby-Zeevi, O., Metzger, S., Chajek-Shaul, T., Gabet, Y., et al (2006) Heparanase is expressed in osteoblastic cells and stimulates bone formation and bone mass. J Cell Physiol. 207, 784\u2013792.","journal-title":"J Cell Physiol."},{"key":"21_CR31_21","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1002\/jcb.21559","volume":"103","author":"W Ariyoshi","year":"2008","unstructured":"Ariyoshi, W., Takahashi, T., Kanno, T., Ichimiya, H., Shinmyouzu, K., Takano, H., et al (2008) Heparin inhibits osteoclastic differentiation and function. J Cell Biochem. 103, 1707\u20131717.","journal-title":"J Cell Biochem."},{"key":"21_CR32_21","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.bbrc.2006.12.221","volume":"354","author":"K Shinmyouzu","year":"2007","unstructured":"Shinmyouzu, K., Takahashi, T., Ariyoshi, W., Ichimiya, H., Kanzaki, S., and Nishihara, T. (2007) Dermatan sulfate inhibits osteoclast formation by binding to receptor activator of NF-kappa B ligand. Biochem Biophys Res Commun. 354, 447\u2013452.","journal-title":"Biochem Biophys Res Commun."},{"key":"21_CR33_21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.bone.2007.04.190","volume":"41","author":"A Irie","year":"2007","unstructured":"Irie, A., Takami, M., Kubo, H., Sekino-Suzuki, N., Kasahara, K., and Sanai, Y. (2007) Heparin enhances osteoclastic bone resorption by inhibiting osteoprotegerin activity. Bone 41, 165\u2013174.","journal-title":"Bone"},{"key":"21_CR34_21","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1002\/jcb.22506","volume":"109","author":"L Ling","year":"2010","unstructured":"Ling, L., Murali, S., Stein, G. S., van Wijnen, A. J., and Cool, S. M. (2010) Glycosaminoglycans modulate RANKL-induced osteoclastogenesis. J Cell Biochem. 109, 1222\u20131231.","journal-title":"J Cell Biochem."},{"key":"21_CR35_21","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1016\/j.bbrc.2006.06.120","volume":"347","author":"S Th\u00e9oleyre","year":"2006","unstructured":"Th\u00e9oleyre, S., Kwan Tat, S., Vusio, P., Blanchard, F., Gallagher, J., Ricard-Blum, S., et al (2006) Characterization of osteoprotegerin binding to glycosaminoglycans by surface plasmon resonance: role in the interactions with receptor activator of nuclear factor kappaB ligand (RANKL) and RANK. Biochem Biophys Res Commun. 347, 460\u2013467.","journal-title":"Biochem Biophys Res Commun."},{"key":"21_CR36_21","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1158\/0008-5472.CAN-08-2648","volume":"69","author":"F Lamoureux","year":"2009","unstructured":"Lamoureux, F., Picarda, G., Garrigue-Antar, L., Baud\u2019huin, M., Trichet, V., Vidal, A., et al (2009) Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res. 69, 526\u2013536.","journal-title":"Cancer Res."},{"key":"21_CR37_21","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1242\/jcs.03310","volume":"120","author":"EJ Chang","year":"2007","unstructured":"Chang, E. J., Kim, H. J., Ha, J., Kim, H. J., Ryu, J., Park, K. H., et al. (2007) Hyaluronan inhibits osteoclast differentiation via Toll-like receptor 4. J Cell Sci. 120, 166\u2013176.","journal-title":"J Cell Sci."},{"key":"21_CR38_21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/jcp.22398","volume":"226","author":"E Pivetta","year":"2011","unstructured":"Pivetta, E., Scapolan, M., Wassermann, B., Steffan, A., Colombatti, A., and Spessotto, P. (2011) Blood-derived human osteoclast resorption activity is impaired by hyaluronan-CD44 engagement via a p38-dependent mechanism. J Cell Physiol. 226, 769\u2013779.","journal-title":"J Cell Physiol."},{"key":"21_CR39_21","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1083\/jcb.200202120","volume":"158","author":"P Spessotto","year":"2002","unstructured":"Spessotto, P., Rossi, F. M., Degan, M., Di Francia, R., Perris, R., Colombatti, A., and Gattei, V. (2002) Hyaluronan-CD44 interaction hampers migration of osteoclast-like cells by down-regulating MMP-9. J Cell Biol. 158, 1133\u20131144.","journal-title":"J Cell Biol."},{"key":"21_CR40_21","doi-asserted-by":"publisher","first-page":"5117","DOI":"10.1074\/jbc.273.9.5117","volume":"273","author":"K Yamaguchi","year":"1998","unstructured":"Yamaguchi, K., Kinosaki, M., Goto, M., Kobayashi, F., Tsuda, E., Morinaga, T., et al (1998) Characterization of structural domains of human osteoclastogenesis inhibitory factor. J Biol Chem. 273, 5117\u20135123.","journal-title":"J Biol Chem."},{"key":"21_CR41_21","doi-asserted-by":"publisher","first-page":"3002","DOI":"10.1182\/blood-2002-04-1190","volume":"100","author":"T Standal","year":"2002","unstructured":"Standal, T., Seidel, C., Hjertner, O., Plesner, T., Sanderson, R. D., Waage, A., et al (2002) Osteoprotegerin is bound, internalized, and degraded by multiple myeloma cells. Blood 100, 3002\u2013 3007.","journal-title":"Blood"},{"key":"21_CR42_21","doi-asserted-by":"publisher","first-page":"2964","DOI":"10.1210\/jc.2004-1895","volume":"90","author":"BA Mosheimer","year":"2005","unstructured":"Mosheimer, B. A., Kaneider, N. C., Feistritzer, C., Djanani, A. M., Sturn, D. H., Patsch, J. R., et al (2005) Syndecan-1 is involved in osteoprotegerin-induced chemotaxis in human peripheral blood monocytes, J Clin Endocrinol Metab. 90, 2964\u20132971.","journal-title":"J Clin Endocrinol Metab."},{"key":"21_CR43_21","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.biocel.2005.03.006","volume":"37","author":"SM Cool","year":"2005","unstructured":"Cool, S. M. and Nurcombe, V. (2005) The osteoblast-heparan sulfate axis: control of the bone cell lineage. Int J Biochem Cell Biol. 37, 1739\u20131745.","journal-title":"Int J Biochem Cell Biol."},{"key":"21_CR44_21","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1359\/JBMR.041014","volume":"20","author":"JJ Cao","year":"2005","unstructured":"Cao, J. J., Singleton, P. A., Majumdar, S., Boudignon, B., Burghardt, A., Kurimoto, P., et al. (2005) Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. J Bone Miner Res. 20, 30\u201340.","journal-title":"J Bone Miner Res."},{"key":"21_CR45_21","doi-asserted-by":"publisher","first-page":"42274","DOI":"10.1074\/jbc.M505720200","volume":"280","author":"CJ Robinson","year":"2005","unstructured":"Robinson, C. J., Harmer, N. J., Goodger, S. J., Blundell, T. L., and Gallagher, J. T. (2005) Cooperative dimerization of fibroblast growth factor 1 (FGF1) upon a single heparin saccharide may drive the formation of 2:2:1 FGF1.FGFR2c.heparin ternary complexes. J Biol Chem. 280, 42274\u201342282.","journal-title":"J Biol Chem"},{"key":"21_CR46_21","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.cytogfr.2005.01.004","volume":"16","author":"M Presta","year":"2005","unstructured":"Presta, M., Dell\u2019Era, P., Mitola, S., Moroni, E., Ronca, R., and Rusnati, M. (2005) Fibroblast growth factor\/fibroblast growth factor receptor system in angiogenesis. Cytokine Growth Factor Rev 16, 159\u2013178.","journal-title":"Cytokine Growth Factor Rev"},{"key":"21_CR47_21","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1074\/jbc.M513414200","volume":"282","author":"X Jiao","year":"2007","unstructured":"Jiao, X., Billings, P. C., O\u2019Connell, M. P., Kaplan, F. S., Shore, E. M., and Glaser, D. L. (2007) Heparan sulfate proteoglycans (HSPGs) modulate BMP2 osteogenic bioactivity in C2C12 cells. J Biol Chem. 282, 1080\u20131086.","journal-title":"J Biol Chem."},{"key":"21_CR48_21","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1002\/jcb.21068","volume":"100","author":"SJ Song","year":"2007","unstructured":"Song, S. J., Cool, S. M., and Nurcombe, V. (2007) Regulated expression of syndecan-4 in rat calvaria osteoblasts induced by fibroblast growth factor-2. J Cell Biochem. 100, 402\u2013411.","journal-title":"J Cell Biochem."},{"key":"21_CR49_21","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1002\/jcp.21825","volume":"220","author":"LM Haupt","year":"2009","unstructured":"Haupt, L. M., Murali, S., Mun, F. K., Teplyuk, N., Mei, L. F., Stein, G. S., et al (2009) The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J Cell Physiol. 220, 780\u2013791.","journal-title":"J Cell Physiol."},{"key":"21_CR50_21","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.mce.2005.09.008","volume":"243","author":"SW Fox","year":"2005","unstructured":"Fox, S. W. and Lovibond, A. C. (2005) Current insights into the role of transforming growth factor-beta in bone resorption. Mol Cell Endocrinol. 243, 19\u201326.","journal-title":"Mol Cell Endocrinol."},{"key":"21_CR51_21","doi-asserted-by":"publisher","first-page":"30481","DOI":"10.1074\/jbc.M500573200","volume":"280","author":"Y Bi","year":"2005","unstructured":"Bi, Y., Stuelten, C. H., Kilts, T., Wadhwa, S., Iozzo, R. V., Robey, P. G., et al (2005) Extracellular matrix proteoglycans control the fate of bone marrow stromal cells. J Biol Chem. 280, 30481\u201330489.","journal-title":"J Biol Chem."},{"key":"21_CR52_21","doi-asserted-by":"publisher","first-page":"30481","DOI":"10.1016\/j.bone.2005.11.005","volume":"38","author":"Y Bi","year":"2006","unstructured":"Bi, Y., Nielsen, K. L., Kilts, T. M., Yoon, A., Karsdal, M. A., Wimer, H. F., et al (2006) Biglycan deficiency increases osteoclast differentiation and activity due to defective osteoblasts, Bone 38, 30481\u201330489.","journal-title":"Bone"},{"key":"21_CR53_21","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1002\/jcp.21557","volume":"217","author":"T Miyazaki","year":"2008","unstructured":"Miyazaki, T., Miyauchi, S., Tawada, A., Anada, T., Matsuzaka, S., and Suzuki, O. (2008) Oversulfated chondroitin sulfate-E binds to BMP-4 and enhances osteoblast differentiation. J Cell Physiol. 217, 769\u2013777.","journal-title":"J Cell Physiol."},{"key":"21_CR54_21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jcp.21700","volume":"219","author":"A Kumarasuriyar","year":"2009","unstructured":"Kumarasuriyar, A., Lee, I., Nurcombe, V., and Cool, S. M. (2009) De-sulfation of MG-63 cell glycosaminoglycans delays in vitro osteogenesis, up-regulates cholesterol synthesis and disrupts cell cycle and the actin cytoskeleton. J Cell Physiol. 219, 572\u2013583.","journal-title":"J Cell Physiol."},{"key":"21_CR55_21","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1182\/blood.V88.4.1314.bloodjournal8841314","volume":"88","author":"JM Muir","year":"1996","unstructured":"Muir, J. M., Andrew, M., Hirsh, J., Weitz, J. I., Young, E., Deschamps, P., and Shaughnessy, S. G. (1996) Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo. Blood 88, 1314\u20131320.","journal-title":"Blood"},{"key":"21_CR56_21","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood.V89.9.3236","volume":"89","author":"JM Muir","year":"1997","unstructured":"Muir, J. M., Hirsh, J., Weitz, J. I., Andrew, M., Young, E., and Shaughnessy, S. G. (1997) A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats. Blood 89, 3236\u20133242.","journal-title":"Blood"},{"key":"21_CR57_21","doi-asserted-by":"crossref","unstructured":"Ruiz-Velasco, C., Baud\u2019huin, M., Sinquin, C., Maillasson, M., Heymann, D., Colliec-Jouault, S., and Padrines, M. (2011) Effects of a sulphated \u2018heparin-like\u2019 exopolysaccharide produced by Altermonas infernus on bone biology. Glycobiology, in press.","DOI":"10.1016\/j.bone.2010.01.195"},{"key":"21_CR58_21","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/S0002-9378(94)70299-3","volume":"170","author":"LA Barbour","year":"1994","unstructured":"Barbour, L. A., Kick, S. D., Steiner, J. F., LoVerde, M. E., Heddleston, L. N., Lear, J. L., et al. (1994) A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry. Am J Obstet Gynecol. 170, 862\u2013869.","journal-title":"Am J Obstet Gynecol."},{"key":"21_CR59_21","first-page":"635","volume":"57","author":"J Folwarczna","year":"2005","unstructured":"Folwarczna, J., Sliwi\u0144ski, L., Janiec, W., and Pikul, M. (2005) Effects of standard heparin and low-molecular-weight heparins on the formation of murine osteoclasts in vitro. Pharmacol Rep. 57, 635\u2013645.","journal-title":"Pharmacol Rep."},{"key":"21_CR60_21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.thromres.2006.10.025","volume":"122","author":"R Rajgopal","year":"2008","unstructured":"Rajgopal, R., Bear, M., Butcher, M. K., and Shaughnessy, S. G. (2008) The effects of heparin and low molecular weight heparins on bone. Thromb Res. 122, 293\u2013298.","journal-title":"Thromb Res."},{"key":"21_CR61_21","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1002\/art.20367","volume":"50","author":"K Nakano","year":"2004","unstructured":"Nakano, K., Okada, Y., Saito, K., and Tanaka, Y. (2004) Induction of RANKL expression and osteoclast maturation by the binding of fibroblast growth factor 2 to heparan sulfate proteoglycan on rheumatoid synovial fibroblasts. Arthritis Rheum. 50, 2450\u20132458.","journal-title":"Arthritis Rheum."}],"container-title":["Methods in Molecular Biology","Proteoglycans"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-61779-498-8_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T19:02:10Z","timestamp":1713380530000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-61779-498-8_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,26]]},"ISBN":["9781617794971","9781617794988"],"references-count":61,"URL":"https:\/\/doi.org\/10.1007\/978-1-61779-498-8_21","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-61779-498-8","asserted-by":"object"}]},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,26]]},"assertion":[{"value":"26 December 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}